Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients

被引:252
作者
Zhou, Jia [2 ]
Ding, Tong [2 ]
Pan, Weidong
Zhu, Ling-yan [2 ]
Li, Lian [1 ,2 ]
Zheng, Limin [2 ,3 ]
机构
[1] Sun Yat Sen Zhongshan Univ, Coll Life Sci, Dept Hepatobiliary Surg, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Zhongshan Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China
[3] Sun Yat Sen Zhongshan Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China
关键词
regulatory T cells; macrophages; hepatocellular carcinoma; DENDRITIC CELLS; TUMOR-IMMUNITY; IMMUNOTHERAPY; INDUCTION; CANCER; STAGE; LIVER; DIFFERENTIATION; PROGRESSION; RECURRENCE;
D O I
10.1002/ijc.24556
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Immunosuppression mediated by regulatory T cells (Trees) is a key facilitator of tumor immune evasion, but the source of these Tregs and their contribution to human cancer progression remains unclear. This study investigated the properties of FoxP3(+) Tregs, their prognostic value in patients with hepatocellular carcinoma (HCC) and the underlying mechanisms of FoxP3(+) Tree intratumoral accumulation. In addition to an increased number of circulating FoxP3(+) Tregs, the results also showed that FoxP3(+) Trees gathered in the tumor site, where they suppressed tissue-derived CD4(+)CD25(-) T-cell activation (p < 0.001), promoting disease progression and poor prognosis in HCC patients (< 0.01). The intratumoral prevalence of FoxP3(+) Tregs was associated with a high density of macrophages (M phi) (p < 0.001). Depletion of tissue M phi thus attenuated the increase of liver FoxP3(+) Tree frequency attributed to in vivo inoculation with hepatoma (p = 0.01), whereas M phi exposed to tumor culture supernatants from hepatoma-derived cell lines increased FoxP3(+) Treg frequency in vitro (p < 0.001). This increase was partially blocked by antiinterleukin-10 antibody (p < 0.01). In conclusion, tumor-associated M phi may trigger a rise of the intratumoral FoxP3(+) Tree population, which in turn may promote HCC progression. (C) 2009 UICC
引用
收藏
页码:1640 / 1648
页数:9
相关论文
共 40 条
[1]
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells [J].
Ai, Weiyun Z. ;
Hou, Ling-Zhou ;
Zeiser, Robert ;
Czerwinski, Debra ;
Negrin, Robert S. ;
Levy, Ronald .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (01) :239-244
[2]
Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[3]
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[4]
Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterisation [J].
Cuury, MP ;
Norris, S ;
Golden-Mason, L ;
Doherty, DG ;
Deignan, T ;
Collins, C ;
Traynor, O ;
McEntee, GP ;
Hegarty, JE ;
O'Farrelly, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 242 (1-2) :21-31
[5]
Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[6]
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients [J].
Fu, Junliang ;
Xu, Dongping ;
Liu, Zhenwen ;
Shi, Ming ;
Zhao, Ping ;
Fu, Baoyun ;
Zhang, Zheng ;
Yang, Huiyin ;
Zhang, Hui ;
Zhou, Chunbao ;
Ya, Jinxia ;
Jin, Lei ;
Wang, Huifen ;
Yang, Yongping ;
Fu, Yang-Xing ;
Wang, Fu-Sheng .
GASTROENTEROLOGY, 2007, 132 (07) :2328-2339
[7]
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection [J].
Gao, Qiang ;
Qiu, Shuang-Jian ;
Fan, Jia ;
Zhou, Jian ;
Wang, Xiao-Ying ;
Xiao, Yong-Sheng ;
Xu, Yang ;
Li, Yi-Wei ;
Tang, Zhao-You .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) :2586-2593
[8]
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation [J].
Ghiringhelli, F ;
Puig, PE ;
Roux, S ;
Parcellier, A ;
Schmitt, E ;
Solary, E ;
Kroemer, G ;
Martin, F ;
Chauffert, B ;
Zitvogel, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :919-929
[9]
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients [J].
Ghiringhelli, Francois ;
Menard, Cedric ;
Puig, Pierre Emmanuel ;
Ladoire, Sylvain ;
Roux, Stephan ;
Martin, Francois ;
Solary, Eric ;
Le Cesne, Axel ;
Zitvogel, Laurence ;
Chauffert, Bruno .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (05) :641-648
[10]
Clinical cancer advances 2007: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology [J].
Gralow, Julie ;
Ozols, Robert F. ;
Bajorin, Dean F. ;
Cheson, Bruce D. ;
Sandler, Howard M. ;
Winer, Eric P. ;
Bonner, James ;
Demetri, George D. ;
Curran, Walter, Jr. ;
Ganz, Patricia A. ;
Kramer, Barnett S. ;
Kris, Mark G. ;
Markman, Maurie ;
Mayer, Robert J. ;
Raghavan, Derek ;
Ramsey, Scott ;
Reaman, Gregory H. ;
Sawaya, Raymond ;
Schuchter, Lynn M. ;
Sweetenham, John W. ;
Vahdat, Linda T. ;
Davidson, Nancy E. ;
Schilsky, Richard L. ;
Lichter, Allen S. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :313-325